FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to biotechnology. Presented is the bacteriocin producing strain Lactobacillus pentosus DSM 21980. The strain is used as a therapeutic agent for controlling gram-negative bacteria, preferentially Enterococci, Coliform bacteria, E. coli, reducing or inhibiting the presence thereof. What is also presented is using the strain for the preventive or curative treatment of gastroenteritis or gastoenterocolitis, infections caused by the above bacteria. The strain can be used as an ingredient of the pharmaceutical composition used as a therapeutic agent. Besides, the strain is used as an ingredient of the food composition applicable as a processing additive added to a starter culture for producing dairy products.
EFFECT: group of inventions provides inhibiting the gram-negative bacteria, preferentially E coli.
15 cl, 4 dwg, 3 tbl
